Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology

Go back to Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology
AXOGEN (NASDAQ: AXGN) Delayed: 44.74 -0.54 (1.19%)
Previous Close $45.28    52 Week High $9.88 
Open $44.94    52 Week Low $4.52 
Day High $45.66    P/E N/A 
Day Low $44.60    EPS $-1.18 
Volume 366,053